JAZZ

Jazz Pharmaceuticals (JAZZ)

About Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$230.94

Daily low

$222.93

Price at open

$225.27

52 Week High

$243.32

52 Week Low

$105.00

Market cap

14.2B

Dividend yield

0.00%

Volume

850,499

Avg. volume

969,208

P/E ratio

-12,278.26

Jazz Pharmaceuticals News